Steglatro

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. STEGLATRO® This medicine is subject to additional monitoring. This will allow quick identificationof new safety information. You can help by reporting any side effects you may get.You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems. Ertugliflozin pyroglutamic acid Consumer Medicine Information What is in […]

Read more

Trajenta

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TRAJENTA CMI0133-09 Tablets linagliptin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Trajenta. It does not contain all the available information. It does not take the place of talking to your doctor, pharmacist or diabetes educator. All medicines have risks […]

Read more

Humalog U200

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. HUMALOG® U200 KwikPen Insulin Lispro (rbe) Consumer Medicine Information What is in this leaflet This leaflet is designed to provide you with answers to some common questions about this medicine. It does not contain all the available information and does not take the place of talking with […]

Read more